Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/15770517

Download in:

View as

General Info

PMID
15770517